| RS2519131361 |
USP9X
|
Health Risk |
Pathogenic |
— |
| RS2519132097 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2519132239 |
MAOA
|
Health Risk |
Pathogenic |
Brunner syndrome, Brunner syndrome |
| RS2519133218 |
USP9X
|
Health Risk |
Likely pathogenic |
— |
| RS2519133759 |
TUBGCP6
|
Health Risk |
Likely pathogenic |
Microcephaly and chorioretinopathy 1, Microcephaly and chorioretinopathy 1 |
| RS2519135002 |
TUBGCP6
|
Health Risk |
Likely pathogenic |
TUBGCP6-related disorder, TUBGCP6-related disorder |
| RS2519136614 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS2519137163 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2519137871 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS2519138293 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2519138333 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2519138457 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2519139321 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2519139379 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2519139558 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Congenital stationary night blindness 2A, Congenital stationary night blindness 2A |
| RS2519139712 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2519140321 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2519140512 |
PCNT
|
Health Risk |
Likely pathogenic |
— |
| RS2519141206 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2519143252 |
CACNA1F
|
Health Risk |
Pathogenic |
X-linked cone-rod dystrophy 3, X-linked cone-rod dystrophy 3 |
| RS2519143271 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Congenital stationary night blindness 2A, Congenital stationary night blindness 2A |
| RS2519143355 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2519147043 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS2519147078 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2519147386 |
TANGO2
|
Health Risk |
Pathogenic/Likely pathogenic |
Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome, Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome |
| RS2519148209 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2519148962 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Thyroid cancer |
| RS2519151963 |
TUBGCP6
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly and chorioretinopathy 1, Microcephaly and chorioretinopathy 1 |
| RS2519155952 |
USP9X
|
Health Risk |
Pathogenic |
— |
| RS2519156130 |
USP9X
|
Health Risk |
Likely pathogenic |
— |
| RS2519156202 |
USP9X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 99 |
| RS2519156797 |
LARGE1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy type B6, Muscular dystrophy-dystroglycanopathy type B6 |
| RS2519159409 |
PCNT
|
Health Risk |
Likely pathogenic |
— |
| RS2519160173 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS2519160574 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS2519163494 |
XK
|
Health Risk |
Likely pathogenic |
Elevated circulating creatine kinase concentration, Elevated circulating creatine kinase concentration |
| RS2519163580 |
XK
|
Health Risk |
Pathogenic |
— |
| RS2519166848 |
USP27X
|
Health Risk |
Likely pathogenic |
— |
| RS2519167013 |
USP27X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 105 |
| RS2519167465 |
USP27X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 105 |
| RS2519167480 |
USP27X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 105 |
| RS2519167657 |
USP27X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 105 |
| RS2519174814 |
BMP15
|
Health Risk |
Pathogenic |
— |
| RS2519174939 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2519175029 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2519178309 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS2519180310 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2519182359 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2519183618 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS2519185601 |
FOXP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2519185876 |
FOXP3
|
Health Risk |
Likely pathogenic |
FOXP3-related disorder, FOXP3-related disorder |
| RS2519186384 |
FOXP3
|
Health Risk |
Pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2519186420 |
FOXP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2519189201 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519189260 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519189282 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519189288 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519190847 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519192078 |
FOXP3
|
Health Risk |
Likely pathogenic |
FOXP3-related disorder, FOXP3-related disorder |
| RS2519194123 |
FOXP3
|
Health Risk |
Likely pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2519194266 |
FOXP3
|
Health Risk |
Likely pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2519196832 |
FOXP3
|
Health Risk |
Pathogenic |
Centronuclear myopathy, Centronuclear myopathy |
| RS2519197052 |
FOXP3
|
Health Risk |
Likely pathogenic |
FOXP3-related disorder, FOXP3-related disorder |
| RS2519197917 |
MYH7B
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy 1 |
| RS2519198695 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519198782 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519199772 |
CASK
|
Health Risk |
Pathogenic |
Developmental disorder, Developmental disorder |
| RS2519199990 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS2519200004 |
MID1
|
Health Risk |
Pathogenic |
— |
| RS2519200090 |
CYBB
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS2519200663 |
MID1
|
Health Risk |
Likely pathogenic |
— |
| RS2519200725 |
MID1
|
Health Risk |
Likely pathogenic |
— |
| RS2519201544 |
MID1
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS2519201923 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519201935 |
CYBB
|
Health Risk |
Conflicting classifications of pathogenicity |
Granulomatous disease, chronic |
| RS2519202036 |
CYBB
|
Health Risk |
Likely pathogenic |
— |
| RS2519203450 |
MYH7B
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Dilated cardiomyopathy with left ventricular noncompaction |
| RS2519204472 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519204505 |
CYBB
|
Health Risk |
Pathogenic |
CYBB-related disorder, CYBB-related disorder |
| RS2519204556 |
USP9X
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2519204575 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519204598 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519206714 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519206740 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519208678 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519208716 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519208752 |
CYBB
|
Health Risk |
Likely pathogenic |
— |
| RS2519208804 |
CYBB
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS2519208868 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519208920 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519208929 |
CYBB
|
Health Risk |
Pathogenic |
Chronic granulomatous disease, Chronic granulomatous disease |
| RS2519208931 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519209274 |
GK
|
Health Risk |
Likely pathogenic |
GK-related disorder, GK-related disorder |
| RS2519209810 |
CYBB
|
Health Risk |
Likely pathogenic |
— |
| RS2519209820 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519210990 |
CYBB
|
Health Risk |
Pathogenic/Likely pathogenic |
Granulomatous disease, chronic |
| RS2519211018 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519211098 |
CYBB
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS2519211145 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2519213323 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |